Urogen Pharma (URGN) Earns “Buy” Rating from Oppenheimer

Retrieved on: 2019-04-02 20:41:50

Tags for this article:

Click the tags to see associated articles and topics

Urogen Pharma (URGN) Earns “Buy” Rating from Oppenheimer. View article details on HISWAI:

Excerpt

<div><b>WINTON GROUP</b> Ltd acquired a new stake in Urogen Pharma in the third quarter worth $221,000. Finally, JPMorgan Chase & Co. acquired a new ...</div>

Article found on:

View Original Article